Oscar Health, Inc.

NYSE OSCR

Oscar Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2024: USD 90.84 M

Oscar Health, Inc. EBITDA is USD 90.84 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 131.03% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Oscar Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -292.72 M, a 46.61% change year over year.
Oscar Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -548.25 M, a -1.38% change year over year.
Oscar Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -540.80 M.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

NYSE: OSCR

Oscar Health, Inc.

CEO	Mr. Mark Thomas Bertolini
IPO Date	March 3, 2021
Location	United States
Headquarters	75 Varick Street
Employees	2,400
Sector	Health Care
Industries Health Insurance & Plans Insurance Pharmaceuticals

Description

Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

Key trends

Past 5 years